BACKGROUND: The risk factors for ventricular arrhythmias in patients with coronary vasospasm have not been identified. We evaluated QT dispersion in patients with vasospastic angina and its relation to susceptibility to ventricular arrhythmias during myocardial ischemia and reperfusion. METHODS AND RESULTS: We assessed the corrected QT (QTc) dispersion before induction of coronary artery spasm by intracoronary injection of acetylcholine (baseline) and 30 minutes after administration of isosorbide dinitrate in 50 patients with vasospastic angina and 50 patients with atypical chest pain. The baseline QTc dispersion was significantly greater in patients with vasospastic angina than in patients with atypical chest pain (mean+/-SD: 69+/-24 versus 44+/-19 ms, 95% confidence interval of mean difference [CI]: 16 to 33 ms; P<0.001). QTc dispersion decreased significantly, to 48+/-15 ms (CI: 15 to 26 ms; P<0.001 versus baseline), after administration of isosorbide dinitrate in patients with vasospastic angina but did not change significantly in patients with atypical chest pain (mean+/-SD: 41+/-17 ms, CI: -3 to 9 ms). During the provocation test, 24 of 50 patients with vasospastic angina experienced ventricular arrhythmias. The baseline QTc dispersion was significantly greater in patients with than without ventricular arrhythmias (mean+/-SD: 77+/-23 versus 61+/-19 ms, CI: 4 to 26 ms; P<0.05). CONCLUSIONS: Patients with vasospastic angina exhibited an increased baseline QTc dispersion compared with patients with atypical chest pain, which suggests that inhomogeneity of repolarization and susceptibility to ventricular arrhythmias are increased in patients with vasospastic angina, even when asymptomatic. The association between increased QTc dispersion and ventricular arrhythmias during the provocation test suggests that measurement of QT dispersion may help predict which patients with vasospastic angina are at high risk for ventricular arrhythmias during ischemia.
BACKGROUND: The risk factors for ventricular arrhythmias in patients with coronary vasospasm have not been identified. We evaluated QT dispersion in patients with vasospastic angina and its relation to susceptibility to ventricular arrhythmias during myocardial ischemia and reperfusion. METHODS AND RESULTS: We assessed the corrected QT (QTc) dispersion before induction of coronary artery spasm by intracoronary injection of acetylcholine (baseline) and 30 minutes after administration of isosorbide dinitrate in 50 patients with vasospastic angina and 50 patients with atypical chest pain. The baseline QTc dispersion was significantly greater in patients with vasospastic angina than in patients with atypical chest pain (mean+/-SD: 69+/-24 versus 44+/-19 ms, 95% confidence interval of mean difference [CI]: 16 to 33 ms; P<0.001). QTc dispersion decreased significantly, to 48+/-15 ms (CI: 15 to 26 ms; P<0.001 versus baseline), after administration of isosorbide dinitrate in patients with vasospastic angina but did not change significantly in patients with atypical chest pain (mean+/-SD: 41+/-17 ms, CI: -3 to 9 ms). During the provocation test, 24 of 50 patients with vasospastic angina experienced ventricular arrhythmias. The baseline QTc dispersion was significantly greater in patients with than without ventricular arrhythmias (mean+/-SD: 77+/-23 versus 61+/-19 ms, CI: 4 to 26 ms; P<0.05). CONCLUSIONS:Patients with vasospastic angina exhibited an increased baseline QTc dispersion compared with patients with atypical chest pain, which suggests that inhomogeneity of repolarization and susceptibility to ventricular arrhythmias are increased in patients with vasospastic angina, even when asymptomatic. The association between increased QTc dispersion and ventricular arrhythmias during the provocation test suggests that measurement of QT dispersion may help predict which patients with vasospastic angina are at high risk for ventricular arrhythmias during ischemia.
Authors: Antonio Bayés de Luna; Iwona Cygankiewicz; Adrian Baranchuk; Miquel Fiol; Yochai Birnbaum; Kjell Nikus; Diego Goldwasser; Javier Garcia-Niebla; Samuel Sclarovsky; Hein Wellens; Günter Breithardt Journal: Ann Noninvasive Electrocardiol Date: 2014-09 Impact factor: 1.468
Authors: Man Young Park; Eun Yeob Kim; Young Ho Lee; Woojae Kim; Ku Sang Kim; Seung Soo Sheen; Hong Seok Lim; Rae Woong Park Journal: Healthc Inform Res Date: 2011-03-31
Authors: Ki Hong Lee; Hyung Wook Park; Jeong Nam Eun; Jeong Gwan Cho; Nam Sik Yoon; Mi Ran Kim; Yo Han Ku; Hyukjin Park; Seung Hun Lee; Jeong Han Kim; Min Chul Kim; Woo Jin Kim; Hyun Kuk Kim; Jae Yeong Cho; Keun-Ho Park; Doo Sun Sim; Hyun Ju Yoon; Kye Hun Kim; Young Joon Hong; Ju Han Kim; Youngkeun Ahn; Myung Ho Jeong; Jong Chun Park Journal: Korean J Intern Med Date: 2017-08-11 Impact factor: 2.884
Authors: Jae Kwon Kim; Nam-Ho Kim; Ik Sang Shin; Dong Hyo Noh; Yong Cheol Kim; Seung Hwan Kim; Jun Ho Choi; Eun Mi Park; Sang Jae Lee; Kyeong Ho Yun; Nam Jin Yoo; Eun Mi Lee; Seok Kyu Oh; Jin-Won Jeong Journal: Korean Circ J Date: 2009-06-30 Impact factor: 3.243